05/25/2026
Clinical rigor is one of the most important, and often overlooked, parts of pharmacy benefit management. For benefit directors, CFOs, brokers, and consultants, the goal is not just to lower pharmacy costs. The goal is to make sure every clinical and financial decision can be explained, documented, and defended.
That starts with a few basic questions:
→ Is the formulary built by a conflict-free P&T committee?
→ Are prior authorization and step therapy rules clinically appropriate?
→ Are exceptions reviewed consistently?
→ Is non-formulary spend being monitored?
→ Are high-cost drugs being evaluated based on net cost, safety, efficacy, and patient impact?
A clinically rigorous pharmacy benefit does not restrict care. It creates a fair process for determining which drugs should be covered, when exceptions are appropriate, and how the plan can protect both member access and plan assets.
This matters because pharmacy benefit decisions should not be driven by rebates, spread pricing, or hidden financial incentives. They should be driven by evidence, transparency, and a fiduciary standard of care.
When clinical rigor is built into the pharmacy benefit, plan sponsors are in a better position to reduce waste, improve oversight, and support better outcomes for members. That is the standard more self-funded employers should expect.
The essential elements of clinical rigor in pharmacy benefits means a pharmacy claim can look clean and still be wrong.
